前收市價 | 0.0130 |
開市 | 0.0000 |
買盤 | 0.0000 x 0 |
賣出價 | 0.0000 x 0 |
今日波幅 | 0.0000 - 0.0000 |
52 週波幅 | |
成交量 | |
平均成交量 | 225,013 |
市值 | 10,677 |
Beta 值 (5 年,每月) | 1.30 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -2.0560 |
業績公佈日 | 2024年5月07日 - 2024年5月13日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 無 |
Invitae Corporation (NYSE:NVTA), backed by SoftBank Group (OTC:SFTBY) (OTC:SFTBF), is reportedly on the brink of filing for bankruptcy in the coming weeks. The San Francisco-based medical genetics company, grappling with a substantial $1.5 billion debt burden, is enlisting the expertise of restructuring advisers from FTI Consulting and legal counsel from Kirkland & Ellis to navigate its financial challenges. Amidst this financial turmoil, Invitae is actively exploring various strategic options,
Invitae shares have lost more than 80% over the past year and a half.
The allure of Cathie Wood Stocks investing prowess has captured a large audience of investors. Yet, even amidst all of the optimism surrounding her investment strategies, prudent investors must be aware of the potential downside risks. While some of Cathie Wood’s early bets like Tesla have paid off, many of them have lost her clients a ton of money. However, there are some Cathie Wood Stocks to sell, and these. aresome of them. Some investors may argue that her bets on revolutionary technologies